Promising drug trial in narcotic bowel syndrome 16 Feb 2012 0 comments Management of a curious and debilitating bowel condition is a step closer after a small Australian trial of the drug methylnatrexone reported promising results.
Gut-directed hypnotherapy works for years 16 Feb 2012 0 comments The benefits of hypnotherapy in treating children with irritable bowel syndrome or functional abdominal pain last for years, say the authors of the longest follow-up study yet.
5-ASA combination best for ulcerative colitis 8 Feb 2012 0 comments A combined oral and topical 5-aminosalicylates (5-ASA) regimen is more effective than oral treatment alone in inducing remission of ulcerative colitis (UC), a new meta-analysis shows.
Research questions travel risk for IBD patients 8 Feb 2012 0 comments The tendency of IBD patients to avoid travelling due to fear of enteric illness may be unfounded, say the authors of the first research of its kind.
Antidepressant use common in IBD 1 Feb 2012 0 comments Antidepressant use is common among people with inflammatory bowel disease, with almost 30% of patients having taken them and many using them long term.
Infliximab gets the (foot) drop on patient 25 Jan 2012 0 comments Clinicians should be aware of peripheral neuropathy as a rare complication of anti- TNF therapy, experts warn.
Exclusive enteral nutrition protocols needed in Crohn's 25 Jan 2012 0 comments Despite exclusive enteral nutrition probably being as effective as steroids in causing remission in children with Crohn’s disease, its use varies widely.
Northern exposure: further evidence links IBD colder weather 18 Jan 2012 0 comments Those living in warmer climates may have less risk of developing IBD, new research reveals.
Aspirin improves iFOBTs 8 Dec 2010 0 comments Far from compromising iFOBTs, low-dose aspirin roughly doubles the sensitivity of the tests and only slightly lowers their specificity, finds a German study.
Thiopurines for IBD during pregnancy: reassuring safety data 8 Dec 2010 0 comments Continued treatment of inflammatory bowel disease with thiopurines during pregnancy does not appear to increase the risk of congenital abnormalities, data from the large CESAME cohort has indicated.
